• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向疟原虫肝期:亡羊补牢,为时未晚。

Targeting Plasmodium liver stages: better late than never.

机构信息

Department of Infectious Diseases, Heidelberg University School of Medicine, 69120 Heidelberg, Germany.

出版信息

Trends Mol Med. 2011 Sep;17(9):527-36. doi: 10.1016/j.molmed.2011.05.008. Epub 2011 Jul 6.

DOI:10.1016/j.molmed.2011.05.008
PMID:21737347
Abstract

The worldwide burden of malaria can be substantially reduced using existing public health interventions. However, elimination of Plasmodium will require fundamentally different approaches. Novel experimental attenuation strategies for active immunization using knockout strains have recently stimulated renewed interest in whole-parasite vaccine approaches. Preventive drug administration during transmission of wild-type sporozoites is a complementary strategy for eliciting protective immune responses. These whole-cell immunization strategies are based on one fundamental principle: inducing protection by blocking parasite conversion from the clinically silent liver phase to the pathogenic intra-erythrocytic replication cycle. Here, we review the basis, evidence and targets for whole-cell-based vaccination strategies against the liver stage bottleneck in Plasmodium infections and discuss preclinical and clinical research opportunities.

摘要

利用现有的公共卫生干预措施,可以大大减轻疟疾的全球负担。然而,消除疟原虫将需要从根本上采取不同的方法。最近,使用基因敲除株进行主动免疫的新型实验减毒策略激发了人们对全寄生虫疫苗方法的重新兴趣。在传播野生型子孢子期间进行预防性药物给药是诱导保护性免疫反应的一种补充策略。这些全细胞免疫策略基于一个基本原则:通过阻止寄生虫从临床无症状的肝期向致病性红内复制周期的转化来诱导保护。在这里,我们回顾了基于全细胞的针对疟原虫感染肝期瓶颈的疫苗接种策略的基础、证据和靶点,并讨论了临床前和临床研究机会。

相似文献

1
Targeting Plasmodium liver stages: better late than never.靶向疟原虫肝期:亡羊补牢,为时未晚。
Trends Mol Med. 2011 Sep;17(9):527-36. doi: 10.1016/j.molmed.2011.05.008. Epub 2011 Jul 6.
2
Harnessing immune responses against Plasmodium for rational vaccine design.利用针对疟原虫的免疫应答进行合理的疫苗设计。
Trends Parasitol. 2011 Jun;27(6):274-83. doi: 10.1016/j.pt.2011.01.002. Epub 2011 Apr 30.
3
Whole parasite vaccination approaches for prevention of malaria infection.全寄生虫疫苗接种方法预防疟疾感染。
Trends Immunol. 2012 May;33(5):247-54. doi: 10.1016/j.it.2012.02.001. Epub 2012 Mar 7.
4
Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.抗疟原虫红细胞前期全生物体疫苗策略的比较疗效。
Vaccine. 2011 Sep 16;29(40):7002-8. doi: 10.1016/j.vaccine.2011.07.034. Epub 2011 Jul 23.
5
Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.红细胞外期疟疾疫苗的研发:理解宿主-寄生虫免疫生物学是战略成功的关键。
Expert Rev Vaccines. 2002 Oct;1(3):317-40. doi: 10.1586/14760584.1.3.317.
6
Malaria vaccine.疟疾疫苗
Indian J Pathol Microbiol. 1996 Dec;39(5):433-41.
7
Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.转基因疟原虫凸显了全寄生虫疫苗策略的潜力。
Trends Immunol. 2005 Jun;26(6):295-7. doi: 10.1016/j.it.2005.04.005.
8
A whole parasite vaccine to control the blood stages of Plasmodium: the case for lateral thinking.一种控制疟原虫血期的全寄生虫疫苗:横向思维的案例。
Trends Parasitol. 2011 Aug;27(8):335-40. doi: 10.1016/j.pt.2011.03.003. Epub 2011 Apr 21.
9
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.转基因疟原虫作为一种保护性实验性疟疾疫苗。
Nature. 2005 Jan 13;433(7022):164-7. doi: 10.1038/nature03188. Epub 2004 Dec 5.
10
Protective immunity against malaria by 'natural immunization': a question of dose, parasite diversity, or both?通过“自然免疫”产生的抗疟疾保护免疫力:是剂量、寄生虫多样性还是两者兼而有之的问题?
Curr Opin Immunol. 2011 Aug;23(4):500-8. doi: 10.1016/j.coi.2011.05.009. Epub 2011 Jun 28.

引用本文的文献

1
Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development.生成一种基因双减毒伯氏疟原虫寄生虫,其在肝脏晚期发育过程中完全停止生长。
PLoS One. 2024 Dec 31;19(12):e0316164. doi: 10.1371/journal.pone.0316164. eCollection 2024.
2
Hepatocyte targeting the asialoglycoprotein receptor.肝细胞靶向作用于去唾液酸糖蛋白受体。
RSC Med Chem. 2024 Dec 2;16(2):525-544. doi: 10.1039/d4md00652f. eCollection 2025 Feb 19.
3
Comparative analyses of functional antibody-mediated inhibition with anti-circumsporozoite monoclonal antibodies against transgenic Plasmodium berghei.
抗环子孢子蛋白单克隆抗体对转基因伯氏疟原虫的功能抗体介导抑制作用的比较分析。
Malar J. 2023 Nov 7;22(1):335. doi: 10.1186/s12936-023-04765-2.
4
Glycomimetics for the inhibition and modulation of lectins.糖基模拟物抑制和调节凝集素。
Chem Soc Rev. 2023 Jun 6;52(11):3663-3740. doi: 10.1039/d2cs00954d.
5
Five decades of clinical assessment of whole-sporozoite malaria vaccines.半个世纪以来对全孢子疟疾疫苗的临床评估。
Front Immunol. 2022 Sep 8;13:977472. doi: 10.3389/fimmu.2022.977472. eCollection 2022.
6
The striking mimics between COVID-19 and malaria: A review.COVID-19 与疟疾的惊人相似之处:综述。
Front Immunol. 2022 Aug 23;13:957913. doi: 10.3389/fimmu.2022.957913. eCollection 2022.
7
Genetics of Malaria Inflammatory Responses: A Pathogenesis Perspective.疟疾炎症反应的遗传学:从发病机制角度看。
Front Immunol. 2019 Jul 30;10:1771. doi: 10.3389/fimmu.2019.01771. eCollection 2019.
8
Infected RBC flag/parameter provided by Mindray BC-6800 haematology analyzer aid the diagnosis of malaria.迈瑞 BC-6800 血液分析仪提供的感染 RBC 标记/参数有助于疟疾的诊断。
Malar J. 2019 Jul 31;18(1):262. doi: 10.1186/s12936-019-2890-z.
9
A sporozoite-based vaccination platform against human malaria.一种基于子孢子的抗人类疟疾疫苗接种平台。
NPJ Vaccines. 2018 Aug 24;3:33. doi: 10.1038/s41541-018-0068-2. eCollection 2018.
10
A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.一种全面评估针对间日疟原虫和恶性疟原虫肝期治疗的模型。
Nat Commun. 2018 May 9;9(1):1837. doi: 10.1038/s41467-018-04221-9.